Skip to main content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

An official website of the United States government
Grant Details

Grant Number: 5U01CA097414-09 Interpret this number
Primary Investigator: Tsodikov, Alexander
Organization: University Of Michigan At Ann Arbor
Project Title: Population Impact of Cancer Control Processes
Fiscal Year: 2009


Abstract

DESCRIPTION (provided by applicant): During the first two years of our active CISNET project "Survival Effects of Prostate Cancer Surveillance" a population model of prostate cancer incidence and mortality was developed and applied to analyze national population and cancer registry data. The new application will focus on using the model to understand, predict and optimize the population impact of cancer control processes in prostate cancer. Specifically, we will study the joint effect of progress in treatment of prostate cancer and dissemination of PSA on observed national incidence and mortality trends; make short- and long-term predictions of the trends; analyze racial disparities as they pertain to dissemination of PSA testing, natural history of prostate cancer, benign disorders in the prostate, dissemination of treatment, survival, incidence and mortality; assess the effect of misattribution bias on the patterns of prostate cancer mortality; evaluate the sensitivity of estimates of population impact of screening interventions and treatment on mortality; assess the impact of Transurethral Resection of the Prostate (TURP) on early detection of prostate cancer and population trends in the pre-PSA era; develop unbiased assessment of treatment effects from population data; translate the results of clinical and prevention trials, and retrospective analyses of clinical data in prostate cancer into the potential population impact of their dissemination; determine and evaluate optimal screening strategies and predict their effect on future national trends in prostate cancer incidence and mortality; develop a user-friendly interface for the model.



Publications

Error Notice

The database may currently be offline for maintenance and should be operational soon. If not, we have been notified of this error and will be reviewing it shortly.

We apologize for the inconvenience.
- The DCCPS Team.

Back to Top